Molecular Tumor Board - A Registry of the East German Hematology and Oncology Study Group.
Recruiting
- Conditions
- hematologic or oncologic diseases
- Registration Number
- DRKS00032977
- Lead Sponsor
- Martin-Luther-Universität Halle-Wittenberg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Signed consent form
- Hematological or oncological disease
- Present question regarding molecular diagnostics or therapy
Exclusion Criteria
No questioning in the context of the molecular tumor board
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Generation of a molecular map in hematology and oncology
- Secondary Outcome Measures
Name Time Method - Number of patients with hemato-oncologic disease and molecular issues.<br>- Consideration of the collected registry data both longitudinally and transversally <br>- Outcome of the patients in dependence of the collected diseases and their specific characteristics, especially the molecular biological characteristics and the therapy sequences<br>- Outcome of patients depending on the molecular biological characteristics of their hematologic or oncologic disease<br>- Outcome as a function of the quality of life assessed against the background of the course of the disease<br>- Analysis of the MTB recommendations and their adherence<br>- Influence of patient-related factors (sociodemographics) on the primary and the mentioned secondary endpoints